Generate Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Generate Investment Management's REGN Position: Q2 2026 in Review
Generate Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 369% in Q2 2026, buying an estimated $12.3M and bringing the position to 23,000 shares worth $14.3M. The position accounts for 0.59% of the portfolio, ranked #43.
Generate Investment Management first reported a position in REGN in Q1 2024 and has held it in 7 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Generate Investment Management held 23,000 shares of Regeneron Pharmaceuticals worth $14.3M as of Q2 2026.
- Generate Investment Management bought 18,092 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.3M.
- Regeneron Pharmaceuticals made up 0.59% of Generate Investment Management's portfolio in Q2 2026, its #43 holding.
- Generate Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.